Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Marcia K. Horn"'
Autor:
Bonnie Addario, Jan Geissler, Marcia K. Horn, Linda U. Krebs, Deborah Maskens, Kathy Oliver, Ananda Plate, Erin Schwartz, Nicole Willmarth
Publikováno v:
Health Expectations, Vol 23, Iss 1, Pp 41-51 (2020)
Abstract Context Patient‐reported outcomes (PROs) are used in parallel with clinical evidence to inform decisions made by industry, clinicians, regulators, health technology assessment bodies and other health‐care decision‐makers. In addition,
Externí odkaz:
https://doaj.org/article/905a28ee91614c4eb6dd98134b36a837
Autor:
Marcia K. Horn, JD, Kevin Liu, PharmD, Susan D. Mathias, MPH, Hilary H. Colwell, MPH, Tracy Li, PhD, Parthiv Mahadevia, MD, Renee F. Pierson, MBA
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100198- (2021)
Introduction: NSCLCs account for most lung cancers; approximately 30% involve a mutation in the EGFR gene. This study sought to identify one or more patient-reported outcome (PRO) measures relevant for use in clinical trials to assess symptoms and he
Externí odkaz:
https://doaj.org/article/007f08dcb59b4e358b3f323f0d033ab7
Autor:
Deborah Maskens, Kathy Oliver, Bonnie J Addario, Nicole Willmarth, Linda U. Krebs, Ananda Plate, Jan Geissler, Marcia K. Horn, Erin S. Schwartz
Publikováno v:
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Health Expectations, Vol 23, Iss 1, Pp 41-51 (2020)
Health Expectations, Vol 23, Iss 1, Pp 41-51 (2020)
Context Patient‐reported outcomes (PROs) are used in parallel with clinical evidence to inform decisions made by industry, clinicians, regulators, health technology assessment bodies and other health‐care decision‐makers. In addition, PRO data
Autor:
Hilary H. Colwell, Tracy Li, Kevin Liu, Marcia K. Horn, Susan D. Mathias, P. Mahadevia, Renee Pierson
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100198-(2021)
Introduction NSCLCs account for most lung cancers; approximately 30% involve a mutation in the EGFR gene. This study sought to identify one or more patient-reported outcome (PRO) measures relevant for use in clinical trials to assess symptoms and hea
Publikováno v:
Journal of Thoracic Oncology. 16:S792
Autor:
Nikki A. Martin, Janelle Schrag, Cynthia Bens, Claire Saxton, Victor J. Gonzalez, Erica Kuhn, Ronit I. Yarden, Marcia K. Horn, Cassadie Moravek, Gillian W. Hooker, Deborah A. Zajchowski, Christine Verini, Andrea K. Miyahira, Sue Friedman, Reese Garcia, Denisse Montoya, Janine Guglielmino, Beth Davison, Stacie Lindsey
Publikováno v:
Journal of Clinical Oncology. 38:e24164-e24164
e24164 Background: Biomarker testing has advanced precision medicine in cancer. However, not all eligible patients benefit from biomarker-driven therapies due to suboptimal testing rates. A working group of 20 patient advocacy groups representing sol